Forget the “FANG” group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.
When biotech stocks are rallying, they’re a play on pure innovation… and the upside is practically infinite.
After all, biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.
Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.
In my newest White Paper, I share the full research on my 3 favorite “biotech breakouts” — 3 companies that could bring investors transformational, life-changing profits. (Simply tell us where to send your report in the box below.)
You can access Hilary Kramer’s full report at no charge by subscribing in the box above. As a special bonus, you’ll receive a complimentary subscription to Hilary’s weekly e-letter, The Trading Desk, which features actionable investing ideas you can put to use right away in your own portfolio.
Just enter your email in the box above to access your free report.